search
Back to results

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes (E-RCT)

Primary Purpose

Type 2 Diabetes, Sleep, Stress

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfunlness Meditation
Sponsored by
University of Illinois at Chicago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Type 2 Diabetes

Eligibility Criteria

21 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria

  • Self-identifies as African American or Black
  • Diagnosis of type 2 diabetes
  • Valid address in greater Chicagoland area
  • Mobile phone with unlimited text-messaging
  • Mobile device (smartphone, tablet, or computer) with the ability to connect to the internet if remote online delivery
  • Availability to participate in mindfulness class either in-person or online
  • Age 21-75

Exclusion Criteria

  • Untreated obstructive sleep apnea (OSA)
  • Severe insomnia, narcolepsy, or REM sleep related disorder
  • Major cognitive impairments or psychiatric disorder
  • Alcohol or drug abuse
  • Limited English proficiency
  • Inability to send/receive text messages
  • Currently engaging in mindfulness practice

Sites / Locations

  • University of Illinois at ChicagoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Mindfulness Meditation Classes

Usual Care

Arm Description

8 mindfulness classes: Participants will engage in 8 two-hour mind and body practice classes over 8 weeks in-person or online (during the pandemic). You will receive compensation for your participation and a yoga mat. You will need to wear comfortable clothing. These sessions can be done sitting in chair, sitting on the floor, or standing. Text messaging., in between classes you will receive text messages to encourage mind and body practices at home. Text messaging may appear as the following: 1.Do you have time to meditate right now? Yes or No. 2.Did you practice your mindfulness today? Yes or no. 3.Remember to wind down this evening and do not drink any caffeinated beverages 4 hours before bed.

Outcomes

Primary Outcome Measures

Sleep Quality
Will use Pittsburgh Sleep Quality Index (PSQI). PSQI has a minimum score of 0 (better) and maximum of 21 (worse). Score > 5 is considered poor quality sleep.
Perceived Stress
Will use Perceived Stress Scale. Scale has a minimum value of 0, and maximum value of 40. Scores from 0-13 are considered low stress, 14-26 are moderate, and 27-40 are high perceived stress.
Sleep Disturbances
Will use Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form 8b. Scores are reported as T-scores, with 28.9 being the minimum value, and 76.5 being the maximum. Higher scores indicate greater sleep disturbances.
Sleep Impairment
Will use Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Related Impairment Short Form 8a.Scores are reported as T-scores, with 30.0 being the minimum value, and 80.1 being the maximum. Higher scores indicate greater sleep impairment.

Secondary Outcome Measures

Cardiovascular Risk
Fasting lipid profile (total cholesterol, HDL, LDL and triglycerides) and blood pressure will be combined to estimate 10 year cardiovascular risk using the American College of Cardiology Atherosclerotic Cardiovascular Disease (ACC ASCVD) Risk Estimator Plus Calculator.
Hemoglobin A1c
Will use HbgA1c as a measure for determining cardiovascular risk.
Inflammatory Markers
IL-6, CRP, TNF-alpha

Full Information

First Posted
December 10, 2021
Last Updated
January 11, 2023
Sponsor
University of Illinois at Chicago
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT05208164
Brief Title
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
Acronym
E-RCT
Official Title
My ESSENCE - Mindfulness to Reduce Stress, Improve SIeep, and Reduce Cardiovascular Risk in African-Americans With Type 2 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2021 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Illinois at Chicago
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The proposed research and training will allow Dr. Alana Biggers to obtain critical research skills and study a mindfulness meditation program designed to improve sleep and reduce stress in African-American adults with diabetes. If effective, this program may reduce the risk of cardiovascular disease among African-Americans with type 2 diabetes who are at high risk of cardiovascular disease.
Detailed Description
African-Americans have disproportionate rates of cardiovascular disease (CVD) in the US. African-Americans with type 2 diabetes (T2DM) have twice the risk than non-Hispanic whites for developing CVD. Poorer sleep and greater chronic psychological stress may contribute to this additional risk. Consequently, African-Americans have worse glycemic control among those with diabetes and higher CVD risk. One promising approach to improving CVD risk in African-Americans is mindfulness meditation (MM). MM can potentially reduce cardiovascular risk through attention control, emotional regulation, and self-awareness. The overall purpose of this K01 training grant is for Dr. Alana Biggers to obtain research training and develop skills needed to become an independent investigator, and use those skills to adapt and evaluate an established MM curriculum. The specific aims are to: (1) adapt and refine an established MM curriculum for African-Americans with T2DM and incorporate text messaging; (2) conduct an 8-week, pilot randomized, controlled trial of the adapted curriculum with up to 100 African-Americans with T2DM(goal of 68 for study completion); and (3) explore the impact of the intervention on cardiometabolic risk factors (blood pressure, glycosylated hemoglobin, and lipid profile) and inflammatory biomarkers (C-reactive protein, interleukin-6, and tumor necrosis factor α). Primary outcomes will include sleep quality and perceived stress evaluated at baseline, 8, and 16 weeks. The proposed research design consists of a pilot study, utilizes mixed-methods research, and involves both primary data collection and analysis. Participants will be randomized 1:1 to either the MM intervention or control. Patients will be assigned to fill cohorts so that those in intervention group will attend MM classes together. A cohort represents a group of 10-12 subjects enrolled within a 1-month time period. MM classes will guide participants in learning and implementing MM practices over 8 weeks. Data collection will occur at baseline, 8 weeks (completion of MM sessions), and 16 weeks. The 16-week data assessment will evaluate MM practice beyond the MM class structure to assess for sustainability. This K01 training grant will provide Dr. Biggers career-building activities to further develop skills and a knowledge base in quantitative and qualitative methodology, health disparities research, and mobile health (mHealth)/behavioral health strategies in minority populations. With the guidance of an interdisciplinary mentorship team and institutional support, Dr. Biggers will receive the necessary assistance and training to work toward her long-term career goal of being an independent researcher with expertise in health disparities, mixed-methods, and mHealth behavioral research.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes, Sleep, Stress

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Group A will be assigned as the intervention group and Group B will be assigned as the usual care group. During the pilot RCT, Group A will run in parallel with Group B.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mindfulness Meditation Classes
Arm Type
Experimental
Arm Description
8 mindfulness classes: Participants will engage in 8 two-hour mind and body practice classes over 8 weeks in-person or online (during the pandemic). You will receive compensation for your participation and a yoga mat. You will need to wear comfortable clothing. These sessions can be done sitting in chair, sitting on the floor, or standing. Text messaging., in between classes you will receive text messages to encourage mind and body practices at home. Text messaging may appear as the following: 1.Do you have time to meditate right now? Yes or No. 2.Did you practice your mindfulness today? Yes or no. 3.Remember to wind down this evening and do not drink any caffeinated beverages 4 hours before bed.
Arm Title
Usual Care
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Mindfunlness Meditation
Intervention Description
Sleep monitoring, mental health promotion and active enrollment/engagement in self-described coping mechanisms
Primary Outcome Measure Information:
Title
Sleep Quality
Description
Will use Pittsburgh Sleep Quality Index (PSQI). PSQI has a minimum score of 0 (better) and maximum of 21 (worse). Score > 5 is considered poor quality sleep.
Time Frame
Change from baseline at 8 and 16 weeks.
Title
Perceived Stress
Description
Will use Perceived Stress Scale. Scale has a minimum value of 0, and maximum value of 40. Scores from 0-13 are considered low stress, 14-26 are moderate, and 27-40 are high perceived stress.
Time Frame
Change from baseline at 8 and 16 weeks.
Title
Sleep Disturbances
Description
Will use Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form 8b. Scores are reported as T-scores, with 28.9 being the minimum value, and 76.5 being the maximum. Higher scores indicate greater sleep disturbances.
Time Frame
Change from baseline at 8 and 16 weeks
Title
Sleep Impairment
Description
Will use Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Related Impairment Short Form 8a.Scores are reported as T-scores, with 30.0 being the minimum value, and 80.1 being the maximum. Higher scores indicate greater sleep impairment.
Time Frame
Change from baseline at 8 and 16 weeks
Secondary Outcome Measure Information:
Title
Cardiovascular Risk
Description
Fasting lipid profile (total cholesterol, HDL, LDL and triglycerides) and blood pressure will be combined to estimate 10 year cardiovascular risk using the American College of Cardiology Atherosclerotic Cardiovascular Disease (ACC ASCVD) Risk Estimator Plus Calculator.
Time Frame
Change from baseline at 8 weeks
Title
Hemoglobin A1c
Description
Will use HbgA1c as a measure for determining cardiovascular risk.
Time Frame
Change from baseline at 8 weeks.
Title
Inflammatory Markers
Description
IL-6, CRP, TNF-alpha
Time Frame
Change from baseline at 8 and 16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria Self-identifies as African American or Black Diagnosis of type 2 diabetes Valid address in greater Chicagoland area Mobile phone with unlimited text-messaging Mobile device (smartphone, tablet, or computer) with the ability to connect to the internet if remote online delivery Availability to participate in mindfulness class either in-person or online Age 21-75 Exclusion Criteria Untreated obstructive sleep apnea (OSA) Severe insomnia, narcolepsy, or REM sleep related disorder Major cognitive impairments or psychiatric disorder Alcohol or drug abuse Limited English proficiency Inability to send/receive text messages Currently engaging in mindfulness practice
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alana Biggers, MD, MPH
Phone
312-413-1793
Email
abigger2@uic.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Alyssa Lawrence
Email
amlawre2@uic.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alana Biggers
Organizational Affiliation
University of Illinois at Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Illinois at Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
606012
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Arthi Dutta
Phone
312-413-5372
Email
myessence@uic.edu
First Name & Middle Initial & Last Name & Degree
Alana Biggers, MD, MPH

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes

We'll reach out to this number within 24 hrs